Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT03945643 Completed - Clinical trials for Patent Foramen Ovale

Is Blood Flow Through IPAVA and PFO Related to Breath-hold and SCUBA Diving-induced Pulmonary Hypertension?

Start date: July 1, 2019
Phase: Early Phase 1
Study type: Interventional

In summary, the investigators propose to study elite Croatian breath-hold and SCUBA divers. The investigators will quantify breath-hold hypoxia- and SCUBA diving-induced pulmonary hypertension and right heart function to investigate the relationships between PFO and IPAVA blood flow. The investigators will use a placebo-controlled intervention (sildenafil) to reduce pulmonary arterial pressure in these subjects to examine the impact of the change in pressure (or absence of change) on the relationships determined above.

NCT ID: NCT03945422 Completed - Clinical trials for Premature Jowl and Neck Laxity Following Facialplasty

The Use of RF in Premature Jowl and Neck Laxity Following Facialplasty

Start date: April 15, 2019
Phase: N/A
Study type: Interventional

Study is to evaluate the efficacy of treatment Radio Frequency in premature jowl and neck laxity following facialplasty

NCT ID: NCT03944824 Completed - Clinical trials for Frail Elderly Syndrome

The Effect of Intradialytic Exercise on the Physical Function of People Undergoing Hemodialysis

IDEX
Start date: February 22, 2019
Phase: N/A
Study type: Interventional

The investigators intend to recruit 50 patients into an intradialytic exercise study that will measure the impact of resistance bands exercises under the guidance of an exercise physiologist on the physical function of hemodialysis patients.

NCT ID: NCT03944343 Completed - Clinical trials for Diet Prevention of Metabolic Diseases

Prebiotic Effects on Glucose Tolerance

Start date: October 15, 2019
Phase: N/A
Study type: Interventional

The primary purpose of this project is to evaluate effects in healthy humans on glucose tolerance of cereal products with high amounts of fermentable dietary fibre. Secondary issues are to investigate effects of the test foods on subjective appetite variables, mood variables and gut microbiota composition. The test food products will be consumed in the evening and test variables will be determined the next morning. The study will apply a randomized crossover study design.

NCT ID: NCT03944265 Completed - Clinical trials for Stage IV Lung Cancer AJCC v8

Genetics and Shared Decision Making in Improving Care for Patients With Stage IVA-C Non-small Cell Lung Cancer

Start date: February 8, 2019
Phase: N/A
Study type: Interventional

This trial studies the use of genetics and shared decision making in improving care for patients with stage IVA-C non-small cell lung cancer. Developing educational tools may help patients with non-small cell lung cancer to increase patient treatment knowledge, reduce decisional conflict, and promote treatment shared decision making with their health care providers.

NCT ID: NCT03944187 Completed - Clinical trials for Induction of Labor Affected Fetus / Newborn

Sonographic Assessment for Prediction of Labor Induction Success

Start date: June 1, 2019
Phase:
Study type: Observational

The study is conducted to assess several sonographic parameters for prediction of labor induction success. These parameters include cervical length, fetal head circumference, and fetal head to cervix angle.

NCT ID: NCT03944135 Completed - Clinical trials for Indication for Modification of Patient Cognitive Status

Cognitive Rehabilitation in Older Adults With Neuron-up (CROAN)

Start date: February 15, 2019
Phase: N/A
Study type: Interventional

Introduction. The application of new technologies for cognitive rehabilitation has increased over the last years and has enabled occupational therapists to work more efficiently, minimizing costs and time for analysis, management, and design of activities. Objective. The purpose of the present study was to assess the effect of cognitive intervention using the web platform Neuronup in a group of elderly subjects; the study is based on the dependent variables (memory, attention, and language) analyzed with the abbreviated Barcelona Test. Subjects and Methods. Aquasi-experimental design was carried out with subjects assigned to two groups: a control group (20 subjects) and an experimental group (20 subjects). The abbreviated Barcelona Test was administered to assess patients before and after the intervention with this software to draw conclusions.

NCT ID: NCT03944057 Completed - Clinical trials for Relapse/Refractory Multiple Myeloma

A Study of Evaluating the Safety and Efficacy of ATG-010 in Relapsed Refractory Multiple Myeloma

MARCH
Start date: September 2, 2019
Phase: Phase 2
Study type: Interventional

This is an open-label, single-arm study of ATG-010 (selinexor) plus low-dose Dexamethasone (Sd) in patients with multiple myeloma previously treated with lenalidomide and bortezomib refractory to prior treatment with immunomodulatory agents and proteasome Inhibitors.

NCT ID: NCT03943979 Completed - Obesity, Morbid Clinical Trials

Pilot Study of an Intervention Involving Cognitive Training and tDCS in Morbidly Obese Subjects

Start date: February 25, 2016
Phase: Phase 2
Study type: Interventional

The study aims to: 1) investigate the effects of cognitive training (CT) and combined CT and transcranial direct current stimulation (tDCS) on food intake and 2) to further understand its neuropsychological and neurophysiological basis (i.e. EEG) as well as its impact in endocannabinoids (EC) in a sample of morbidly obese patients seeking for a gastric bypass surgery

NCT ID: NCT03943966 Completed - Stroke Clinical Trials

In-vivo Thrombus Imaging With 18F-GP1, a Novel Platelet PET Radiotracer

iThrombus
Start date: November 11, 2019
Phase: N/A
Study type: Interventional

To date, the investigators have successfully employed a radiotracer (18F-sodium fluoride) as a marker of necrotic inflammation in human atherosclerosis. The investigators aim to further the mechanistic understanding of atherothrombosis by studying the activation of glycoprotein IIb/IIIa receptors in cardiovascular thrombus using the novel platelet radiotracer (18F-GP1). Binding of 18F-GP1 to activated platelets in venous and arterial thrombi has already been demonstrated in pre-clinical studies and a phase 1 trial in man. If successful, this study would define the role of the glycoprotein IIb/IIIa receptor within in vivo thrombosis across a range of cardiovascular diseases.